Header Logo

Connection

Matthew Wanat to Anticoagulants

This is a "connection" page, showing publications Matthew Wanat has written about Anticoagulants.
Connection Strength

2.130
  1. A comparison of anticoagulation, antiplatelet, and placebo treatment for patients with heart failure reduced ejection fraction in sinus rhythm: a systematic review and meta-analysis. Heart Fail Rev. 2020 03; 25(2):207-216.
    View in: PubMed
    Score: 0.672
  2. Management of Anticoagulation with Impella? Percutaneous Ventricular Assist Devices and Review of New Literature. J Thromb Thrombolysis. 2019 Aug; 48(2):284-291.
    View in: PubMed
    Score: 0.645
  3. Novel oral anticoagulants: a review of new agents. Postgrad Med. 2013 Jul; 125(4):103-14.
    View in: PubMed
    Score: 0.423
  4. Group-based trajectory modeling to identify adherence patterns for direct oral anticoagulants in Medicare beneficiaries with atrial fibrillation: a real-world study on medication adherence. Int J Clin Pharm. 2024 Dec; 46(6):1525-1535.
    View in: PubMed
    Score: 0.229
  5. Medication taking behaviors in patients taking warfarin versus direct oral anticoagulants: A systematic review. Expert Rev Cardiovasc Ther. 2019 Jun; 17(6):427-434.
    View in: PubMed
    Score: 0.159
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.